Human Hepatitis B Virus Core Protein Inhibits IFNα-Induced IFITM1 Expression by Interacting with BAF200

Viruses - Tập 11 Số 5 - Trang 427
Tongya Li1, Zunlong Ke1,2, Weiyong Liu1,3, Ying Xiong1, Ying Zhu1, Yingle Liu1
1College of Life Sciences, Wuhan University, Wuhan 430072, China
2Structural Studies Division, MRC Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0QH, UK
3Department of Clinical Laboratory, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China

Tóm tắt

Human hepatitis B virus core protein (HBc) is a structural protein of the hepatitis B virus (HBV) and contributes to HBV regulation of host-cell transcription. However, the mechanisms of transcriptional regulation remain poorly characterized. To dissect the function of HBc, a yeast two-hybrid was performed to identify HBc-binding proteins, and the C-terminal of BRG1/hBRM-associated factors 200 (BAF200C) was identified. Then, the existence of HBc interactions with BAF200C and full-length BAF200 was confirmed via co-immunoprecipitation assays in 293T, HepG2 and HepG2-NTCP cells. Furthermore, we show that the binding between HBc and BAF200 was of vital importance to HBc mediated downregulation of interferon-induced transmembrane protein 1 (IFITM1) expression, and the mechanisms for the downregulation were disclosed as follows. Basal level of IFITM1 expression depends on BAF200, rather than the JAK–STAT1 pathway. The interaction of HBc with BAF200 disturbs the stability of the polybromo-associated BAF (PBAF) complex and results in the suppression of IFTM1 transcription. Finally, the antiviral effects of IFITM1 on cell proliferation and HBV replication were found to be partially restored when HBc was co-transfected with BAF200. Collectively, our findings indicate that HBc plays a role in HBV resistance against the antiviral activities of IFNα, providing details about HBV evasion of host innate immunity.

Từ khóa


Tài liệu tham khảo

Gallucci, L., and Kann, M. (2017). Nuclear import of hepatitis B virus capsids and genome. Viruses, 9.

Wieland, 2004, Genomic analysis of the host response to hepatitis B virus infection, Proc. Natl. Acad. Sci. USA, 101, 6669, 10.1073/pnas.0401771101

Klumpp, 2018, Efficacy of NVR 3–778, alone and in combination with pegylated interferon, vs entecavir in UPA/SCID mice with humanized livers and hbv infection, Gastroenterology, 154, 652, 10.1053/j.gastro.2017.10.017

Busca, 2014, Innate immune responses in hepatitis b virus (HBV) infection, Virol. J., 11, 22, 10.1186/1743-422X-11-22

Porterfield, 2010, Full-length hepatitis B virus core protein packages viral and heterologous RNA with similarly high levels of cooperativity, J. Virol., 84, 7174, 10.1128/JVI.00586-10

Stannard, 1979, Morphological irregularities in DANE particle cores, J. Gen. Virol., 45, 509, 10.1099/0022-1317-45-2-509

Selzer, 2015, Hepatitis B virus core protein phosphorylation sites affect capsid stability and transient exposure of the C-terminal domain, J. Biol. Chem., 290, 28584, 10.1074/jbc.M115.678441

Li, H.C., Huang, E.Y., Su, P.Y., Wu, S.Y., Yang, C.C., Lin, Y.S., Chang, W.C., and Shih, C. (2010). Nuclear export and import of human hepatitis B virus capsid protein and particles. PLoS Pathog., 6.

Xiang, 2015, The hepatitis b virus (HBV) core protein enhances the transcription activation of CRE via the CRE/CREB/CBP pathway, Antivir. Res., 120, 7, 10.1016/j.antiviral.2015.04.013

Kwon, 2002, Hepatitis B viral core protein activates the hepatitis B viral enhancer II/pregenomic promoter through the nuclear factor kappab binding site, Biochem. Cell. Biol., 80, 445, 10.1139/o02-133

Guo, Y., Kang, W., Lei, X., Li, Y., Xiang, A., Liu, Y., Zhao, J., Zhang, J., and Yan, Z. (2012). Hepatitis B viral core protein disrupts human host gene expression by binding to promoter regions. BMC Genom., 13.

Varela, 2011, Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma, Nature, 469, 539, 10.1038/nature09639

Yan, 2005, Pbaf chromatin-remodeling complex requires a novel specificity subunit, baf200, to regulate expression of selective interferon-responsive genes, Genes Dev., 19, 1662, 10.1101/gad.1323805

Lemon, 2001, Selectivity of chromatin-remodelling cofactors for ligand-activated transcription, Nature, 414, 924, 10.1038/414924a

Tupler, 2001, Expressing the human genome, Nature, 409, 832, 10.1038/35057011

Zhao, 2011, Arid2: A new tumor suppressor gene in hepatocellular carcinoma, Oncotarget, 2, 886, 10.18632/oncotarget.355

2001, Noncytolytic control of viral infections by the innate and adaptive immune response, Annu. Rev. Immunol., 19, 65, 10.1146/annurev.immunol.19.1.65

Perreira, 2013, Ifitms restrict the replication of multiple pathogenic viruses, J. Mol. Biol., 425, 4937, 10.1016/j.jmb.2013.09.024

Yu, 2015, IFITM proteins restrict HIV-1 infection by antagonizing the envelope glycoprotein, Cell. Rep., 13, 145, 10.1016/j.celrep.2015.08.055

Wilkins, 2013, IFITM1 is a tight junction protein that inhibits hepatitis c virus entry, Hepatology, 57, 461, 10.1002/hep.26066

Huang, I.C., Bailey, C.C., Weyer, J.L., Radoshitzky, S.R., Becker, M.M., Chiang, J.J., Brass, A.L., Ahmed, A.A., Chi, X., and Dong, L. (2011). Distinct patterns of ifitm-mediated restriction of filoviruses, sars coronavirus, and influenza a virus. PLoS Pathog., 7.

Brass, 2009, IFITM proteins mediate the innate immune response to influenza a H1N1 virus, West Nile virus and dengue virus, Cell, 139, 1243, 10.1016/j.cell.2009.12.017

Ni, 2014, Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes, Gastroenterology, 146, 1070, 10.1053/j.gastro.2013.12.024

Yan, 2012, Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis b and d virus, eLife, 1, e00049, 10.7554/eLife.00049

Bradford, 1976, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding, Anal. Biochem., 72, 248, 10.1016/0003-2697(76)90527-3

Belloni, 2012, IFN-alpha inhibits HBV transcription and replication in cell culture and in humanized mice by targeting the epigenetic regulation of the nuclear cccDNA minichromosome, J. Clin. Investig., 122, 529, 10.1172/JCI58847

Katze, 2002, Viruses and interferon: A fight for supremacy, Nat. Rev. Immunol., 2, 675, 10.1038/nri888

Schneider, 2014, Interferon-stimulated genes: A complex web of host defenses, Annu. Rev. Immunol., 32, 513, 10.1146/annurev-immunol-032713-120231

Dunn, 2009, Temporal analysis of early immune responses in patients with acute hepatitis B virus infection, Gastroenterology, 137, 1289, 10.1053/j.gastro.2009.06.054

Bertoletti, 2013, Innate and adaptive immune responses in chronic hepatitis B virus infections: Towards restoration of immune control of viral infection, Postgrad. Med. J., 89, 294, 10.1136/postgradmedj-2011-301073rep

Li, 2012, Mxa inhibits hepatitis B virus replication by interaction with hepatitis B core antigen, Hepatology, 56, 803, 10.1002/hep.25608

Peltekian, 2005, Human MXA protein participates to the interferon-related inhibition of hepatitis B virus replication in female transgenic mice, J. Hepatol., 43, 965, 10.1016/j.jhep.2005.06.019

Guan, 2007, Interferon-alpha response in chronic hepatitis B-transfected hepg2.2.15 cells is partially restored by lamivudine treatment, World J. Gastroenterol., 13, 228, 10.3748/wjg.v13.i2.228

Du, 2009, Hepatitis B virus core protein inhibits trail-induced apoptosis of hepatocytes by blocking DR5 expression, Cell. Death Differ., 16, 219, 10.1038/cdd.2008.144

Kwon, 2003, Transcriptional repression of the human p53 gene by hepatitis b viral core protein (HBC) in human liver cells, Biol. Chem., 384, 203, 10.1515/BC.2003.022

Lapostolle, 2004, Persistence of cccdna during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy, Gastroenterology, 126, 1750, 10.1053/j.gastro.2004.03.018

Boeijen, 2017, Hepatitis B virus infection and the immune response: The big questions, Best Pract. Res. Clin. Gastroenterol., 31, 265, 10.1016/j.bpg.2017.05.003

Guidotti, 1999, Viral clearance without destruction of infected cells during acute hbv infection, Science, 284, 825, 10.1126/science.284.5415.825

Thông tin
Thông tin xuất bản

Viruses

Tập 11 Số 5

427

Thông tin tác giả